you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Apr 09, 16:00
4759.50 69.30 (1.48%)
Volume
AVERAGE VOLUME
5-Day
47,674
10-Day
42,076
30-Day
52,281
60,061
  • Prev. Close

    4690.20

  • Open Price

    4690.20

  • Bid Price (Qty.)

    4760.00 (20)

  • Offer Price (Qty.)

    4774.00 (45)

NSE Live

Apr 09, 15:59
4760.30 71.25 (1.52%)
Volume
AVERAGE VOLUME
5-Day
922,189
10-Day
856,418
30-Day
945,894
1,362,147
  • Prev. Close

    4689.05

  • Open Price

    4692.90

  • Bid Price (Qty.)

    4760.30 (54)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Dr Reddys Laboratories (in Rs. Cr.) Sep '20 Mar '20 Sep '19 Mar '19 Sep '18  
Net Sales/Income from operations 6,570.40 5,881.90 5,954.70 5,312.10 5,154.60  
Other Operating Income 19.80 13.80 -- 64.80 94.00  
Total Income From Operations 6,590.20 5,895.70 5,954.70 5,376.90 5,248.60  
EXPENDITURE  
Consumption of Raw Materials 1,604.70 1,327.30 1,229.20 1,069.40 1,033.80  
Purchase of Traded Goods 604.60 572.20 545.00 494.00 374.60  
Increase/Decrease in Stocks -328.70 -32.90 -67.00 81.20 -15.20  
Power & Fuel -- -- -- -- --  
Employees Cost 1,153.00 1,027.80 1,002.40 961.90 970.00  
Depreciation 411.90 388.10 401.10 397.70 382.90  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses 1,799.30 -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses -- 1,724.80 1,653.60 1,646.90 1,719.20  
P/L Before Other 1,345.40 888.40 1,190.40 725.80 783.30  
Other Income 659.30 196.70 548.10 165.50 82.90  
P/L Before Int. 2,004.70 1,085.10 1,738.50 891.30 866.20  
Interest 23.30 23.50 24.30 24.50 32.30  
P/L Before Exceptional Items & Tax 1,981.40 1,061.60 1,714.20 866.80 833.90  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,981.40 1,061.60 1,714.20 866.80 833.90  
Tax 550.20 37.10 -199.00 264.60 158.80  
P/L After Tax from Ordinary Activities 1,431.20 1,024.50 1,913.20 602.20 675.10  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,431.20 1,024.50 1,913.20 602.20 675.10  
Equity Share Capital 83.10 83.10 83.10 83.00 83.00  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 86.31 61.64 115.42 -- 40.67  
Diluted EPS 86.08 -- 115.21 -- 40.62  
EPS After Extra Ordinary  
Basic EPS. 86.31 61.64 115.42 -- 40.67  
Diluted EPS. 86.08 -- 115.21 -- 40.62  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs